Vipul Organics Q1FY27 net profit nearly doubles to ₹252 lakh on revenue growth
Vipul Organics delivered robust Q1FY27 financials, with consolidated PAT jumping nearly 100% YoY to ₹252.46 lakh amidst a 38.44% rise in revenue to ₹5,217.52 lakh. Standalone PBT surged 113% to ₹344.62 lakh, reflecting enhanced operational efficiency. Management highlighted completed capex cycles and upcoming revenue streams from the membrane division as key growth drivers.

*this image is generated using AI for illustrative purposes only.
Vipul Organics Limited reported a significant improvement in profitability for the first quarter of FY27, with consolidated net profit after tax (PAT) rising 99.75% year-on-year to ₹252.46 lakh. The specialty chemicals company posted total revenues of ₹5,217.52 lakh, marking a 38.44% increase from the ₹3,768.81 lakh recorded in Q1FY26.
Profit before tax (PBT) expanded sharply by 113% to ₹344.62 lakh on a standalone basis, outpacing the revenue growth and indicating improved operational efficiency. Earnings per share (EPS) grew 54.65% to ₹1.33 from ₹0.86 in the corresponding period last year on a consolidated basis.
Quarterly Performance
On a quarter-on-quarter basis, revenues remained relatively stable, declining marginally by 0.85% from ₹5,262.38 lakh in Q4FY26. However, profitability metrics showed consistent upward momentum. PBT rose 14.53% to ₹344.47 lakh, while PAT increased 27.93% to ₹252.46 lakh compared to the previous quarter.
| Metric: | Q1FY27 | Q1FY26 | YoY Change |
|---|---|---|---|
| Total Revenue: | ₹5,217.52 lakh | ₹3,768.81 lakh | +38.44% |
| PBT: | ₹344.62 lakh | ₹161.72 lakh | +113% |
| PAT: | ₹252.46 lakh | ₹126.39 lakh | +99.75% |
| EPS: | ₹1.33 | ₹0.86 | +54.65% |
The unaudited financial results for the quarter ended June 30, 2026, were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on August 14, 2026. Statutory auditors carried out a limited review of the standalone and consolidated financial results.
What the Numbers Show
The divergence between revenue growth and profit expansion highlights strong operating leverage. While revenues grew by 38.44%, profit before tax more than doubled with a 113% increase. This suggests that cost optimization initiatives are yielding immediate results, allowing a larger portion of incremental revenue to flow through to the bottom line. The company’s management noted that these efforts are beginning to translate into margin expansion.
Management Outlook
Vipul P. Shah, Managing Director, attributed the results to the continued strength of core businesses and progress in diversification. He stated that the current capital expenditure cycle is now complete, positioning the company for sustained growth. Additionally, the membrane division remains on track to add a new visible revenue stream in the coming quarters. The company is also finalizing its internal multi-decadal roadmap, Vision 2035, which will be shared with shareholders in due course.
Historical Stock Returns for Vipul Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.85% | +2.18% | +12.17% | +39.45% | +38.45% | 0.0% |
How will the completion of the current capital expenditure cycle impact Vipul Organics' free cash flow and debt reduction strategy in FY27?
What specific revenue targets has management set for the membrane division in the upcoming quarters following its integration?
How might the newly finalized 'Vision 2035' roadmap alter the company's capital allocation priorities between organic growth and M&A?


































